Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
Butylphthalide injection (NBP) marketed in China for stroke
>> article
Butylphthalide injection (NBP) marketed in China for stroke
Editor:bianch Clicks:
0
Date:2010-9-16 17:13:32
Keyword:
Butylphthalide injection
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Sodium Lactate Ringer's Injection monthly export report
Huamin passed British GMP for sterile in...
Huamin's Ceftriaxone injection exported to&nbs...
Huamin's Ceftriaxone injection passed Japan&nb...
HengRui's Oxaliplatin injection approved in&nb...
Hengrui's Irinotecan injection exported to&nbs...
Cumberland and Harbin Gloria to sell Ace...
NBP (Butylphthalide) sale reaches 500 Mn ...
Hengrui's Irinotecan injection approved in&nbs...
CSPC ready to launch Biapenem for inject...
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
